Aman Kumar
Independent DirectorDr. Aman Kumar, MD, serves as a Managing Director & Co-Portfolio Manager at Oaktree Capital Management, L.P. Dr. Kumar is involved in Oaktree’s Global Private Debt strategy. He also serves as a co-portfolio manager for the strategy’s Life Sciences Lending platform which focuses on investment opportunities across the healthcare spectrum from biotechnology and pharmaceuticals to medical devices and healthcare services. Dr. Kumar served as Managing Director at Oaktree Capital Management, L.P. from January 2020 till May 2022. He serves as Independent Director of serves as Oaktree Acquisition Corp. III Life Sciences since July 2024. He was Chairman of Oaktree Acquisition Corp. III. Life Sciences from January 6, 2025. Prior to joining Oaktree in 2014, Dr. Kumar spent several years at Deutsche Bank working on the Global Credit team, most recently as a vice president on the European High Yield trading desk. Prior to Wharton, Dr. Kumar worked as a surgeon in the UK National Health Service. He is a member of the Royal College of Surgeons of England. He received an M.B.A. from the Wharton School at the University of Pennsylvania and holds a Bachelor of Medicine, Bachelor of Surgery degree from King’s College London.
公司职务
- 公司名称Oaktree Acquisition Corp. III Life Sciences股票代码OACC职务Independent Director关联证券
- 公司名称Oaktree Specialty Lending Corporation股票代码OCSL职务Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending共事同僚
- APArmen PanossianCEO & Co-Chief Investment Officer
- JBJohn Bernkopf FrankChairman of the Board
- MMMathew M. PendoPresident
- CMChristopher McKownCFO & Treasurer
- BMBrett McKeoneChief Operating Officer
- BEBruce E. ZimmermanLead Independent Director
- CACraig A. JacobsonIndependent Director
- DADeborah Ann GeroIndependent Director
- PRPhyllis R. CaldwellIndependent Director
